- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Primecap Management Co. CA Trims Stake in Health Catalyst
Institutional investor reduces holding in healthcare data analytics firm
Feb. 28, 2026 at 10:59am
Got story updates? Submit your updates here. ›
Primecap Management Co. CA, an institutional investor, reduced its stake in Health Catalyst, Inc. (NASDAQ:HCAT) by 31.1% during the third quarter. The firm now owns 1,369,067 shares, or about 1.95% of the healthcare data and analytics company's stock.
Why it matters
This transaction highlights the volatility in Health Catalyst's stock price and ownership structure. As a public company, Health Catalyst's shares are subject to trading by institutional investors like Primecap Management, whose investment decisions can significantly impact the stock's performance.
The details
According to a regulatory filing, Primecap Management sold 617,620 shares of Health Catalyst during the third quarter. The firm now owns 1,369,067 shares, valued at $3.9 million as of the most recent SEC disclosure. Health Catalyst's stock has traded between $1.61 and $5.06 over the past 52 weeks.
- Primecap Management reduced its stake in Health Catalyst during the third quarter of 2026.
The players
Primecap Management Co. CA
An institutional investment management firm that owns a significant stake in Health Catalyst.
Health Catalyst, Inc.
A healthcare data and analytics technology company based in Salt Lake City, Utah.
The takeaway
This transaction underscores the volatility in Health Catalyst's stock and the shifting investment landscape for healthcare technology companies. As a public firm, Health Catalyst's performance and ownership structure will continue to be closely watched by investors and industry analysts.
